rs78970955
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006612.6(KIF1C):c.2726C>A(p.Pro909Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00539 in 1,613,566 control chromosomes in the GnomAD database, including 402 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_006612.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF1C | NM_006612.6 | c.2726C>A | p.Pro909Gln | missense_variant | 23/23 | ENST00000320785.10 | NP_006603.2 | |
KIF1C | XM_005256424.3 | c.2726C>A | p.Pro909Gln | missense_variant | 24/24 | XP_005256481.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF1C | ENST00000320785.10 | c.2726C>A | p.Pro909Gln | missense_variant | 23/23 | 1 | NM_006612.6 | ENSP00000320821 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0295 AC: 4488AN: 152060Hom.: 223 Cov.: 32
GnomAD3 exomes AF: 0.00819 AC: 2028AN: 247538Hom.: 113 AF XY: 0.00614 AC XY: 826AN XY: 134454
GnomAD4 exome AF: 0.00288 AC: 4214AN: 1461388Hom.: 179 Cov.: 31 AF XY: 0.00245 AC XY: 1779AN XY: 727010
GnomAD4 genome AF: 0.0295 AC: 4491AN: 152178Hom.: 223 Cov.: 32 AF XY: 0.0284 AC XY: 2115AN XY: 74390
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 26, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Spastic ataxia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | May 14, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at